Peripheral Arterial Disease: An Underestimated Aspect of
Menopause-related Cardiovascular Disease

Panagiotis      Anagnostis; Dimitri   P.   Mikhailidis; Ales      Blinc; Mojca      Jensterle; Mateja   K.   Ježovnik; Gerit-Holger      Schernthaner; Pier   Luigi   Antignani; Katica   Bajuk   Studen; Miso      Sabovic; Pavel      Poredos

doi:10.2174/0115701611295374231212110458

« Previous Next »

[1]
Papas T. Management of peripheral arterial disease after menopause. Curr Vasc Pharmacol 2023. Epub ahead of print

[2]
Anagnostis P, Mikhailidis DP, Blinc A, et al. The effect of menopause and menopausal hormone therapy on the risk of peripheral artery disease. Curr Vasc Pharmacol  2023; 21(5): 293-6.
 [http://dx.doi.org/10.2174/0115701611263345230919122907] [PMID:  37779405]

[3]
Poredoš P, Schernthaner GH, Blinc A, et al. Endocrine disorders and peripheral arterial disease: A Series of Reviews. Curr Vasc Pharmacol  2023; 21(3): 147-8.
 [http://dx.doi.org/10.2174/1570161121666230516141319] [PMID:  37194233]

[4]
Anagnostis P, Bitzer J, Cano A, et al. Menopause symptom management in women with dyslipidemias: An EMAS clinical guide. Maturitas  2020; 135: 82-8.
 [http://dx.doi.org/10.1016/j.maturitas.2020.03.007] [PMID:  32209279]

[5]
Leal LG, Lopes MA, Batista ML Jr. Physical exercise-induced myokines and muscle-adipose tissue crosstalk: A review of current knowledge and the implications for health and metabolic diseases. Front Physiol  2018; 9: 1307.
 [http://dx.doi.org/10.3389/fphys.2018.01307] [PMID:  30319436]

[6]
Studen KB, Gaberscek S, Zaletel K, et al. Thyroid disorders and peripheral arterial disease. Curr Vasc Pharmacol 2023;. 21
 [http://dx.doi.org/10.2174/0115701611271284231105063148] [PMID:  37957913]

[7]
R H, A J , Dp M , et al. Growth hormone, atherosclerosis and peripheral arterial disease: Exploring the spectrum from acromegaly to growth hormone deficiency. Curr Vasc Pharmacol 2023. 21
 [http://dx.doi.org/10.2174/0115701611269162231106042956] [PMID:  37962050]

Rights & Permissions Print Cite

Article Metrics

16

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor α(PPARα) Agonists,PPARγ Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells
Current Drug Targets - Cardiovascular & Hematological Disorders

One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology

Research Progress of Diphenyl Urea Derivatives as Anticancer Agents and Synthetic Methodologies
Mini-Reviews in Organic Chemistry

Possible Role of NUCB2/nesfatin-1 in Adipogenesis
Current Pharmaceutical Design

Definitions of Metabolic Syndrome: Where are We Now?
Current Vascular Pharmacology

DOI https://dx.doi.org/10.2174/0115701611295374231212110458	Print ISSN 1570-1611
Publisher Name Bentham Science Publisher	Online ISSN 1875-6212

Current Vascular Pharmacology

Peripheral Arterial Disease: An Underestimated Aspect of Menopause-related Cardiovascular Disease

Advancements in Arterial Stiffness: Novel Therapeutic Frontiers

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Current Vascular Pharmacology

Peripheral Arterial Disease: An Underestimated Aspect of Menopause-related Cardiovascular Disease

Call for Papers in Thematic Issues

Advancements in Arterial Stiffness: Novel Therapeutic Frontiers

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Related Journals

Related Books

Related Articles